International Business News - ACAD http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the earnings stories for Tuesday, Aug. 5, from AP Financial News: Top stories: http://www.ibtimes.com/articles/20080805/earnings-roundup-dr-horton-acadia-pharma.htm Tue, 05 Aug 2008 10:41:13 EDT Acadia Pharmaceuticals Inc. said Tuesday it will cut its work force in half as it restructures to cut expenses and focus on a few late-stage drug candidates. http://www.ibtimes.com/articles/20080805/acadia-slashes-jobs-and-development-to-cut-costs.htm Tue, 05 Aug 2008 09:06:03 EDT Acadia Pharmaceuticals Inc. posted a larger second-quarter loss Tuesday as research costs increased and several drug development collaborations ended, slowing its revenue to a trickle. http://www.ibtimes.com/articles/20080805/acadia-2q-loss-grows-as-partnership-revenue-drops.htm Tue, 05 Aug 2008 09:02:01 EDT Shares of Acadia Pharmaceuticals Inc. jumped Tuesday, after a Banc of America Securities analyst removed his "Sell" rating, citing the stock's rock-bottom valuation. http://www.ibtimes.com/articles/20080708/bofa-analyst-removes-sell-rating-on-acadia-pharma.htm Tue, 08 Jul 2008 15:20:05 EDT Among the premarket stories for Tuesday, June 17, from AP Financial News: NEW YORK (AP)--Analysts turned their attention to Acadia Pharmaceuticals Inc.'s future and its drug candidate pimavanserin Tuesday, a day after the company reported the failure of another schizophrenia drug. http://www.ibtimes.com/articles/20080617/premarket-roundup-acadia-tempur-pedic.htm Tue, 17 Jun 2008 10:12:40 EDT Analysts turned their attention to Acadia Pharmaceuticals Inc.'s future and its drug candidate pimavanserin Tuesday, a day after the company reported the failure of another schizophrenia drug. http://www.ibtimes.com/articles/20080617/ahead-of-the-bell-acadia-pharmaceuticals.htm Tue, 17 Jun 2008 08:50:18 EDT Among the stock activity stories for Monday, June 16, from AP Financial News: NEW YORK (AP)--Shares of Acadia Pharmaceuticals Inc. fell to an all-time low Monday after the biotechnology company said it will probably discontinue a key schizophrenia drug program following a midstage study failure. http://www.ibtimes.com/articles/20080616/movers-roundup-acadia-webmd-health.htm Mon, 16 Jun 2008 14:44:34 EDT Shares of Acadia Pharmaceuticals Inc. fell to an all-time low Monday after the biotechnology company said it will probably discontinue a key schizophrenia drug program following a midstage study failure. http://www.ibtimes.com/articles/20080616/acadia-shares-hit-new-low-on-failed-study.htm Mon, 16 Jun 2008 11:27:19 EDT Biotechnology company Acadia Pharmaceuticals Inc. said Monday a midstage study showed its experimental drug was no better than placebo in treating schizophrenia. http://www.ibtimes.com/articles/20080616/acadia-schizophrenia-drug-fails-mid-stage-trial.htm Mon, 16 Jun 2008 08:25:45 EDT